Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600117211) titled 'ZBED5-AS1: A New Clue for the Diagnostic and Metastatic Mechanisms in Lung Adenocarcinoma' on Jan. 21.
Study Type: Observational study
Study Design:
Case-Control study
Primary Sponsor: The First Affiliated Hospital of Wenzhou Medical University
Condition:
Lung Adenocarcinoma
Intervention:
Healthy individuals:None
Non-metastasis group:None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-01-21
Target Sample Size: Healthy individuals:50;Non-metastasis group:100;Transfer group:100;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?...